Skip to main content

and
  1. Article

    Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Gary Middleton, Peter Fletcher, Sanjay Popat, Joshua Savage, Yvonne Summers in Nature (2020)

  2. No Access

    Article

    The National Lung Matrix Trial of personalized therapy in lung cancer

    The majority of targeted therapies for non-small-cell lung cancer (NSCLC) are directed against oncogenic drivers that are more prevalent in patients with light exposure to tobacco smoke13. As this group represen...

    Gary Middleton, Peter Fletcher, Sanjay Popat, Joshua Savage, Yvonne Summers in Nature (2020)